Paid Clinical Trials in Morgantown, WV
As of July 2026, 226 paid clinical trials are recruiting in Morgantown, West Virginia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Morgantown offers studies at sites including West Virginia University for conditions such as Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Coronary Artery Disease, Ovarian Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Morgantown
Trials by drug in Morgantown
Filter results
Newly added in Morgantown
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
202 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
The CONFORM Pivotal Trial
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Galleri® in the Medicare Population.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Registry for Stage 2 Type 1 Diabetes
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Top Research Study Locations in Morgantown
Researchers run research studies in Morgantown, WV at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| West Virginia University | Stroke, Atrial Fibrillation, Breast Cancer | 67 |
| West Virginia University Healthcare | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 48 |
| West Virginia University Cancer Institute | Breast Cancer, CD19 Positive, CRC (Colorectal Cancer) | 6 |
| West Virginia University Hospital | Cardiovascular Disease and Lipoprotein(a), Heart Failure NYHA Class III, Heart Failure NYHA Class IV | 6 |
| West Virginia University Medicine | Aorta; Lesion, Aortic Aneurysm, Thoracic, Aortic Dissection | 6 |
| West Virginia University Hospitals | Irritable Bowel Syndrome, Atopic Dermatitis, Alopecia Areata | 4 |
| WVU Cancer Institute | Breast Cancer, Multiple Myeloma, Ovarian Cancer | 3 |
| WVU Rockefeller Neuroscience Institute | Dementia, Fibromyalgia, Opioid Use Disorder | 3 |
| Ascendis Investigational Site | Hypoparathyroidism | 2 |
| Frontier Clinical Research | Acute Migraine, Migraine | 2 |
| WVU Medicine | Aortic Dissection, Heart Failure, Obesity | 2 |
| WVU Medicine Children's Hospital | Growth, Pre-term Infants, Respiratory Distress Syndrome | 2 |
| West Virginia Clinical and Translational Science Institute | COPD, COVID-19, Coronavirus Infections | 2 |
| West Virginia University - Morgantown | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 2 |
| West Virginia University Cancer Institute Mary Babb Randolph Cancer Center | Adenocarcinoma of the Pancreas, Gallbladder Adenocarcinoma | 2 |
| West Virginia University Heart and Vascular Institute | Circadian Rhythm Disorders, Type 2 Diabetes | 2 |
| West Virginia University Hospitals Inc | Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Infusion Reactions | 2 |
| United BioSource LLC | CIDP - Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis, Birth Outcomes, Adverse | 2 |
| West Virginia University School of Medicine | Chronic Lymphocytic Leukemia, Epithelial Ovarian Cancer, Fallopian Tube Cancer | 2 |
| West Virginia Childrens Hospital | Familial Hypercholesterolemia - Heterozygous | 1 |
| Aaron Cumpston | Hematological Malignancy, Neutropenia | 1 |
| Amy Miller, RPh, PharmD | Ischemic Stroke | 1 |
| Ascentage Investigative | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL | 1 |
| Clinical Trial Site | Prosthetic-joint Infection | 1 |
| Frontier Clinical Research Waterfront | Respiratory Syncytial Virus Infections | 1 |
Active & Upcoming Studies in Morgantown (2026)
Recruiting trials in Morgantown grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (84 active studies)
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
- A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014) · Phase 3 · Merck Sharp & Dohme LLC
Cardiovascular (18 active studies)
- Tailored MgSO4 Supplementation to Reduce Complications in Pediatric Heart Surgery · West Virginia University
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Neurology & pain (17 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Diabetes & metabolic (7 active studies)
- Cardiometabolic Impact of a Produce Prescription Program in Patients With Type 2 Diabetes and Food Insecurity · West Virginia University
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
Mental health & behavior (4 active studies)
- Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY) · University of Oklahoma
- rTMS-concurrent Behavioral Priming for Reducing Smoking Cravings · West Virginia University
Vaccines (3 active studies)
- A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease · Phase 2 · Shionogi
- Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID · Phase 3 · Wes Ely
Eye & vision (1 active study)
- Clarifying the Optimal Application of SLT Therapy Trial · Phase 3 · University of Pittsburgh
Pediatric (1 active study)
- Talk With Me Baby to Enhance the Early Home Language Environment · IDeA States Pediatric Clinical Trials Network
Common conditions studied in Morgantown
- Breast Cancer (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Coronary Artery Disease (4 active studies)
- Ovarian Cancer (4 active studies)
- Stroke (4 active studies)
- Atopic Dermatitis (3 active studies)
Leading research sponsors in Morgantown
- West Virginia University
- National Cancer Institute (NCI)
- AstraZeneca
- SWOG Cancer Research Network
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Morgantown?
There are approximately 226 recruiting clinical trials in Morgantown, West Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Morgantown pay participants?
Most recruiting trials in Morgantown compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Morgantown?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Morgantown?
The most common conditions under active study in Morgantown include Breast Cancer (6), Anatomic Stage II Breast Cancer AJCC v8 (4), Coronary Artery Disease (4), Ovarian Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Morgantown?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Morgantown on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Morgantown?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Morgantown?
Recruiting research sites in Morgantown include West Virginia University, West Virginia University Healthcare, West Virginia University Cancer Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Morgantown right now?
The largest active categories in Morgantown are Cancer & tumors (84), Cardiovascular (18), Neurology & pain (17). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.